Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer

BACKGROUND: Pathological complete remission (pCR) of estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer is rarely achieved after neoadjuvant chemotherapy (NAC). In addition, the prognostic value of pCR for this breast cancer subtype is limited. We...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Breast Cancer Res
Glavni autori: Loo, Claudette E., Rigter, Lisanne S., Pengel, Kenneth E., Wesseling, Jelle, Rodenhuis, Sjoerd, Peeters, Marie-Jeanne T. F. D. Vrancken, Sikorska, Karolina, Gilhuijs, Kenneth G. A.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4975876/
https://ncbi.nlm.nih.gov/pubmed/27495815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0742-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items